[Influence of clinical characteristics of diabetes upon the development and course of diabetic retinopathy with particular reference to anabolic steroid therapy].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications; D002648:Child; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D005260:Female; D005654:Fundus Oculi; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D013997:Time Factors
D045930:Anabolic Agents
Wplyw klinicznych cech cukrzycy na rozwój i przebieg retinopatii cukrzycowej ze szczególnym uwzglednieniem leczenia sterydami anabolizujacymi.